Article
A Novel Epigenetic Signature for Early Diagnosis in Lung Cancer
3 Feb 2016
Abstract excerpt
PURPOSE: Lung cancer remains as the leading cause of cancer-related death worldwide, mainly due to late diagnosis. Cytology is the gold-standard method for lung cancer diagnosis in minimally invasive respiratory samples, despite its low sensitivity. We aimed to identify epigenetic biomarkers with clinical utility for cancer diagnosis in minimally/noninvasive specimens to improve accuracy of current technologies....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
